Patient Monitoring

PUBLISHER: 360iResearch | PRODUCT CODE: 1306153

PUBLISHER: 360iResearch | PRODUCT CODE: 1306153

Immunoprecipitation Market by Product, Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED: June 12, 2023

PAGES: 187 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The Global Immunoprecipitation Market is forecasted to grow significantly, with a projected USD 1,369.76 million in 2023 at a CAGR of 20.71% and expected to reach a staggering USD 5,136.86 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoprecipitation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunoprecipitation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Accessories, Beads, Kits, and Reagents. The Accessories is further studied across Primary Antibodies and Secondary Antibodies. The Beads is further studied across Agarose Beads, Buffers, and Magnetic Beads. The Beads is projected to witness significant market share during forecast period.

Based on Type, market is studied across Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation, and RNA Immunoprecipitation. The Individual Immunoprecipitation is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunoprecipitation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunoprecipitation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoprecipitation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoprecipitation Market?

4. What is the competitive strategic window for opportunities in the Global Immunoprecipitation Market?

5. What are the technology trends and regulatory frameworks in the Global Immunoprecipitation Market?

6. What is the market share of the leading vendors in the Global Immunoprecipitation Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunoprecipitation Market?

Product Code: MRR-43676CF42C66

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunoprecipitation Market, by Product, 2022 vs 2030
4.3. Immunoprecipitation Market, by Type, 2022 vs 2030
4.4. Immunoprecipitation Market, by End-User, 2022 vs 2030
4.5. Immunoprecipitation Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing applications of immunoprecipitation testing in central nervous disorders
  - 5.1.1.2. Rise in the number of life science experiments and research activities
  - 5.1.1.3. Development of improved protocols for chromatin immunoprecipitation
- 5.1.2. Restraints
  - 5.1.2.1. Presence of alternative technologies for protein purification
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in immunoprecipitation techniques
  - 5.1.3.2. Rising investments by governments and various industries
- 5.1.4. Challenges
  - 5.1.4.1. Issues related to quality over research antibodies
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Immunoprecipitation Market, by Product

6.1. Introduction
6.2. Accessories
- 6.2.1. Primary Antibodies
- 6.2.2. Secondary Antibodies
6.3. Beads
- 6.3.1. Agarose Beads
- 6.3.2. Buffers
- 6.3.3. Magnetic Beads
6.4. Kits
6.5. Reagents

7. Immunoprecipitation Market, by Type

7.1. Introduction
7.2. Chromatin Immunoprecipitation
7.3. Co-Immunoprecipitation
7.4. Individual Immunoprecipitation
7.5. RNA Immunoprecipitation

8. Immunoprecipitation Market, by End-User

8.1. Introduction
8.2. Academic & Research Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Immunoprecipitation Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Immunoprecipitation Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Immunoprecipitation Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

Product Code: MRR-43676CF42C66

LIST OF FIGURES

FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOPRECIPITATION MARKET SIZE, 2022 VS 2030
FIGURE 3. IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 6. IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 7. IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. IMMUNOPRECIPITATION MARKET DYNAMICS
FIGURE 9. IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. IMMUNOPRECIPITATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOPRECIPITATION MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOPRECIPITATION MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOPRECIPITATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOPRECIPITATION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOPRECIPITATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOPRECIPITATION MARKET SIZE, BY CHROMATIN IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOPRECIPITATION MARKET SIZE, BY CO-IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOPRECIPITATION MARKET SIZE, BY INDIVIDUAL IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IMMUNOPRECIPITATION MARKET SIZE, BY RNA IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 43. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 44. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 48. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 70. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 71. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 75. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 76. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 85. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 115. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 131. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 136. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 141. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 146. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 161. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 162. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 176. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 181. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 182. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 186. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 187. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 221. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 235. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 236. IMMUNOPRECIPITATION MARKET LICENSE & PRICING

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ